Biomarker Menu
Biomarker Menu

Explore Our Biomarker Menu

Including 400+ Biomarker Offerings for a Range of Disease States

Return to Biomarker Menu

Biomarker: sMet

Search for Biomarkers

Analyte:

sMet

Platform:

Matrix:

null

Disease State:

null

Status:

Offered

Required Sample Volume:

null

Biological or Clinical Significance:

Met is a receptor tyrosine kinase often expressed in epithelium. Its paracrine ligand, hepatocyte growth factor (“scatter factor”), is produced by stromal cells. Met signals via Ras, pi3k/Akt, and stat, affecting mitosis, survival, angiogenesis, migration, invasion, and as implied, mesenchymal–epithelial transversion. Upregulation in cancer cells results in “invasive growth.” Amplification of MET is documented in 4.1% of North American lung adenocarcinomas, but MET overexpression maybe more commonc. Mutations in MET occur rarely.

References:

Speak to a Scientist

















What would you like to discuss?

With whom will we be speaking?






I consent to receive communications (which may include, phone, email, social, and re-targeting ads) from BioAgilytix. I understand I may proactively manage my preferences or opt-out of communications with BioAgilytix at any time using the unsubscribe link provided in all of BioAgilytix’s email communications and can learn more by reading the privacy policy.

Yes I confirm that I am over the age of 16 and I consent to communications from BioAgilytix.


biomarker services

Services

See how our premier bioanalytical services support all phases of biomarker, immunogenicity, PK, and cell-based assay studies.

Explore our services

case studies

Case Studies

Learn why we’re a trusted partner to 22 of the top 25 global pharma and biotech companies.

Read our case studies